Ciappenelli Robert D. 4

4 · Dicerna Pharmaceuticals Inc · Filed Jan 12, 2021

Form 4

Period: 2021-01-08

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2021-01-08+5,775→ 5,775 total
Tax Payment
Common Stock
2021-01-08$23.29/sh−2,002$46,627→ 3,773 total
Exercise/Conversion
Restricted Stock Units
2021-01-08−5,775→ 17,325 total
→ Common Stock (5,775 underlying)
Award
Restricted Stock Units
2021-01-12+13,700→ 13,700 total
→ Common Stock (13,700 underlying)
Award
Employee Stock Option (Right to Buy)
2021-01-12+61,500→ 61,500 total
Exercise: $24.05Exp: 2031-01-11→ Common Stock (61,500 underlying)

Footnotes (5)

[F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
[F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
[F3]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of January 8, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
[F4]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
[F5]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2021, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued employment or service with the Issuer through each applicable vesting date.

Documents

2 files